Gyn onc consult triage
Should I Consult Gynecologic Oncology?
A concise triage aid for known or suspected gynecologic malignancy.
Copyable consult message
Gyn Onc Consult Dotphrase
Reason for Consult: *** HPI: *** Clinical Question: *** Pending: *** Callback: *** Thank you!
Best practices for gyn onc consults
- State whether malignancy is known, suspected, or only part of the differential.
- Include the key imaging finding, pathology result, tumor marker context, or exam concern that prompted the question.
- Make the clinical question specific: disposition, admission service, biopsy route, operative planning, staging, treatment planning, or outpatient referral timing.
- List pending imaging, pathology, outside records, tumor markers, or pelvic exam information so the consultant knows what is still missing.
- Include a direct callback number and urgency if the decision changes ED disposition, transfer, admission, or operative planning.
Gyn Onc consults FAQ
Common Gyn Onc Consult Questions
Should every adnexal mass be referred to gyn onc?
No. Low-risk or clearly benign-appearing findings often follow benign gynecology or surveillance pathways. Gyn onc becomes more relevant when imaging is highly suspicious, malignancy is confirmed, or surgical/staging decisions may change. *†
Is an elevated CA-125 enough for gyn onc consultation?
Usually not by itself. Tumor markers are most useful in context with imaging, exam findings, menopausal status, symptoms, and pathology. Isolated lab concern often needs additional diagnostic workup first. †
When is tissue diagnosis needed before gyn onc referral?
It depends on the clinical picture. Confirmed gynecologic malignancy should generally prompt gyn onc involvement, but highly suspicious imaging can also justify early discussion before biopsy if the biopsy route, surgery, staging, or disposition may be affected. *†
What makes a gyn onc consult easier to answer?
A focused consult question, concise oncologic history, key imaging or pathology, current acuity, disposition pressure, and pending studies. The most useful consult asks what decision needs gyn onc input today.
References
- * ACR O-RADS US risk stratification and management guidance for ovarian/adnexal lesions.
- † ACOG/SGO adnexal mass referral criteria overview summarized in referral guidance for patients with adnexal masses.
- ACOG/SGO Committee Opinion on the obstetrician-gynecologist role in early ovarian cancer detection and referral considerations.
- ASCO resource-stratified guideline for ovarian masses and epithelial ovarian cancer treatment pathways.
- NCCN Guidelines for Patients for ovarian, fallopian tube, and primary peritoneal cancers.
Educational tool only. SIC provides clinician-facing educational consult-triage references. SIC does not diagnose, treat, prevent, cure, or mitigate disease and is not a substitute for clinical judgment, local guidelines, institutional referral pathways, or recommendations from your gynecologic oncology department. See disclaimer.